Drug Type Small molecule drug |
Synonyms ZD19-0144 |
Target |
Mechanism MEK inhibitors(Dual specificity mitogen-activated protein kinase kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
BRAF V600E Mutation-Positive Melanoma | Preclinical | RU | 30 Nov 2022 | |
Colorectal Cancer | Preclinical | RU | 30 Nov 2022 |